Kestra Medical Technologies, Ltd. entered into a $200.0 million five-year senior secured term loan facility with BPCR Limited Partnership and BioPharma Credit Investments V (Master) LP. The facility is divided into four tranches: a $75.0 million Tranche A loan (funded on July 10, 2020, 26), a $25.0 million Tranche B loan, a $50.0 million Tranche C loan (contingent on revenue), and a $50.0 million uncommitted Tranche D loan for acquisitions. Tranche A net proceeds of approximately $20.0 million were used to repay the Prior Loan Agreement with Perceptive Credit Holdings IV, LP and to fund general corporate and working capital requirements. The term loans mature on July 10, 2031, and bear interest at a variable rate of 5.50% plus three-month SOFR (floor of 3.25%). Kestra Medical Technologies, Ltd. is a medical technology company that develops and manufactures medical devices for the treatment of cardiac and cardiac-related issues.